Agios Soars on Plan to Promote Most cancers Medication, Go back $1.2B to Holders

Shares of Agios Pharmaceuticals  (AGIO) – Get Report jumped Monday after the drugmaker agreed to sell its oncology portfolio to French pharmaceutical firm Servier for up to $2 billion.

Read More: | For More Business Articles | Visit Our Facebook & Twitter @kbcchanneltv | Making The Invisible, Visible

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker
%d bloggers like this: